| Dr Edward T Wolanski, MD | |
|
600 Peter Jefferson Pkwy Ste 300, Charlottesville, VA 22911-8837 | |
| (434) 293-9800 | |
| (434) 977-0088 |
| Full Name | Dr Edward T Wolanski |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 42 Years |
| Location | 600 Peter Jefferson Pkwy Ste 300, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578544953 | NPI | - | NPPES |
| DG6598 | Other | VA | MEDICARE RAILROAD GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101039930 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Martha Jefferson Hospital | Charlottesville, VA | Hospital |
| Entity Name | Edward T Wolanski Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225193972 PECOS PAC ID: 9739212424 Enrollment ID: O20100802000512 |
News Archive
Patients with inflammatory bowel disease are at an increased risk of stroke and heart attack according to a new study presented by Mayo Clinic researchers at the American College of Gastroenterology's Annual Scientific Meeting, Oct. 11-16, in San Diego.
A small protein may have a big role in helping you make more bone and less fat, researchers say. "The pathways are parallel, and the idea is if you can somehow disrupt the fat production pathway, you will get more bone," says Dr. Xingming Shi, bone biologist at the Medical College of Georgia Institute of Molecular Medicine and Genetics.
Eli Lilly and Company and its wholly owned subsidiary, Avid Radiopharmaceuticals, Inc., have received a complete response letter from the U.S. Food and Drug Administration for their New Drug Application for Amyvid, a Positron Emission Tomography imaging agent under investigation for the detection of beta-amyloid plaque in the brains of living patients.
Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).
Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward T Wolanski, MD 600 Peter Jefferson Pkwy, Suite 300, Charlottesville, VA 22911-8835 Ph: (434) 293-9800 | Dr Edward T Wolanski, MD 600 Peter Jefferson Pkwy Ste 300, Charlottesville, VA 22911-8837 Ph: (434) 293-9800 |
News Archive
Patients with inflammatory bowel disease are at an increased risk of stroke and heart attack according to a new study presented by Mayo Clinic researchers at the American College of Gastroenterology's Annual Scientific Meeting, Oct. 11-16, in San Diego.
A small protein may have a big role in helping you make more bone and less fat, researchers say. "The pathways are parallel, and the idea is if you can somehow disrupt the fat production pathway, you will get more bone," says Dr. Xingming Shi, bone biologist at the Medical College of Georgia Institute of Molecular Medicine and Genetics.
Eli Lilly and Company and its wholly owned subsidiary, Avid Radiopharmaceuticals, Inc., have received a complete response letter from the U.S. Food and Drug Administration for their New Drug Application for Amyvid, a Positron Emission Tomography imaging agent under investigation for the detection of beta-amyloid plaque in the brains of living patients.
Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).
Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS.
› Verified 1 days ago
Donald J. Dudley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22908 Phone: 434-924-2500 Fax: 434-244-9487 | |
Christian A. Chisholm, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-2500 Fax: 434-244-9487 | |
Jennifer Doorey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2955 Ivy Rd Ste 304, Charlottesville, VA 22903 Phone: 434-243-4570 Fax: 434-295-5491 | |
Evan Jacob Kraus, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Peter Jefferson Pkwy, Charlottesville, VA 22911 Phone: 434-977-4488 | |
Charles N. Landen Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1240 Lee St, Charlottesville, VA 22908 Phone: 434-924-5100 Fax: 434-982-1840 | |
Dr. Linnea Rose Goodman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4100 Olympia Cir Ste 201, Charlottesville, VA 22911 Phone: 434-220-6620 Fax: 434-220-6621 | |
Ms. Whitney Dijon Archie-patrick, FNP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2955 Ivy Rd Ste 304, Charlottesville, VA 22903 Phone: 434-243-4570 Fax: 434-295-5491 |